SCHEMBL16654876

SCHEMBL16654876

CCS(=O)(=O)c1ccc(OC)c(-c2cn(C)c(=O)c3ccc(-c4c[nH]nc4C)cc23)c1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654965 0.92 BRD4 (0.69) BRD4
SCHEMBL16654363 0.91 BRD4 (0.58) BRD4
SCHEMBL16654866 0.88 BRD4 (0.53) BRD4
SCHEMBL16654754 0.85 BRD4 (0.69) BRD4
SCHEMBL29849059 0.84 BRD4 (0.75) BRD4
SCHEMBL16651312 0.84 BRD4 (0.75) BRD4
SCHEMBL16654853 0.83 BRD4 (0.70) BRD4
SCHEMBL16658118 0.83 BRD4 (0.75) BRD4
SCHEMBL16715340 0.82 BRD4 (0.69) BRD4
SCHEMBL16655112 0.82 BRD4 (0.50) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057586-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2016-08-24 EP disclosed
WO-2015058160-A1 BROMODOMAIN INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2015-04-23 WO disclosed